Hormonal and biochemical changes during treatment of endometriosis with the luteinizing hormone-releasing hormone (LH-RH) agonist [D-Trp6,des-Gly-NH210]LH-RH ethylamide
article
OA: closed
CC0
⤵ 9 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
AI-generated summary
This study investigated hormonal and biochemical alterations in women with endometriosis undergoing treatment with the LH-RH agonist [D-Trp6, des-Gly-NH210]LH-RH ethylamide.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (27)
- Administration of Nasal Nafarelin as Compared with Oral Danazol for Endometriosis via openalex
- Danazol and gestagen displacement of testosterone and influence on sex-hormone-binding globulin capacity via openalex
- Endometriosis: Role of Ovarian Steroids in Initiation, Maintenance, and Suppression via openalex
- Endometriosis: treatment with gonadotropin-releasing hormone agonist Buserelin via openalex
- “MEDICAL OOPHORECTOMY” USING A LONG-ACTING GNRH AGONIST-A POSSIBLE NEW APPROACH TO THE TREATMENT OF ENDOMETRIOSIS. via openalex
- W1987997754 via openalex
- W1993886776 via openalex
- W2012742352 via openalex
- W2041953935 via openalex
- W2056041193 via openalex
- W2059859570 via openalex
- W2070739986 via openalex
- W2093353943 via openalex
- W2151690571 via openalex
- W2408870186 via openalex
- W2409164901 via openalex
- W2415755045 via openalex
- W2477008945 via openalex
- W6601913206 via openalex
- W6642239427 via openalex
- W6661309070 via openalex
- W48040828 via openalex
- W6724743285 via openalex
- W616990441 via openalex
- W1491858567 via openalex
- W1967012029 via openalex
- W1967983161 via openalex
Cited by (9)
- Treatment of Endometriosis with the GnRHa Deslorelin and Add-Back Estradiol and Supplementary Testosterone 2015
- Use of aromatase inhibitors in gynecology 2010
- Caveats associated with the use of human cervical tissue for HIV and microbicide research 2009
- Traitements des localisations urologiques de l'endométriose 2009
- Aromatase inhibitors prevent the estrogen rise associated with the flare effect of gonadotropins in patients treated with GnRH agonists 2008
- Endocrine effects of GnRH analogue with low‐dose hormone replacement therapy in women with endometriosis 1995
- GnRH Agonists in the Treatment of Endometriosis 1993
- 9 Endometriosis: Medical therapy 1993
- Estrogenic suppression by different administration schedules of goserelin depot for treatment of endometriosis 1993
Source provenance
- europepmc
- last seen: 2026-06-11T06:19:48.454388+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-05-13T22:12:10.587122+00:00
License: CC0
· commercial use OK